Ignite Creation Date:
2024-05-05 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00663806
Status:
COMPLETED
Last Update Posted:
2014-12-02
First Post:
2008-04-17
Brief Title:
A Phase IV Study of Cipro XR in Uncomplicated UTI
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
EXPRESS Evaluating Cipro XR Patient Response Education Safety and Satisfaction
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EXPRESS
Brief Summary:
Safety and efficacy of Cipro XR in a naturalistic setting and the effectiveness of an educational brochure - Women with urinary tract infections were treated with Cipro XR They were also given a brochure with information about urinary tract infections and later tested on the information
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None